Japan Cancer Biopsy Market was valued at USD 0.80 Billion in 2022 and is projected to reach USD 1.30 Billion by 2030, growing at a CAGR of 6.80% from 2024 to 2030.
The Japan cancer biopsy market is segmented into several key applications, each playing a crucial role in diagnosing and treating various types of cancer. One of the primary applications is the biopsy for breast cancer detection. Breast cancer remains one of the most prevalent cancers in Japan, making early detection and accurate diagnosis essential. Biopsy techniques such as fine needle aspiration (FNA) and core needle biopsy are commonly used to obtain tissue samples from suspicious areas in the breast. These methods help pathologists determine the presence and type of cancer cells, guiding subsequent treatment decisions. Advances in biopsy technologies continue to improve the precision and efficiency of these procedures, contributing to better patient outcomes in breast cancer management.
Another significant application is the biopsy for prostate cancer. Prostate cancer is a common malignancy among Japanese men, and biopsy is a critical tool for diagnosis. Transrectal ultrasound-guided biopsy (TRUS) and magnetic resonance imaging (MRI)-guided biopsy are commonly employed to sample prostate tissue. These methods help in identifying cancerous lesions and determining the aggressiveness of the disease. The development of targeted biopsy techniques has enhanced the ability to detect prostate cancer early and accurately, thereby improving the management and treatment strategies for patients.
Get an In-Depth Research Analysis of the Japan Cancer Biopsy Market Size And Forecast [2025-2032]
Qiagen N.V.
Illumina
Inc
ANGLE Plc
Myriad Genetics
Hologic
Inc
Biocept
Inc
Thermo Fisher Scientific
Inc
Danaher
Lucence Diagnostics Pte. Ltd.
GRAIL
Inc
Guardant Health
Exact Sciences Corporation
Freenome Holdings
Inc
Oncimmune
Chronix Biomedical
Inc
Personal Genome Diagnostics Inc
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Japan Cancer Biopsy Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Japan Cancer Biopsy Market
Breast Cancer
Colorectal Cancer
Cervical Cancers
Lung Cancers
Prostate Cancers
Skin Cancers
Blood Cancers
Kidney Cancers
Others
Based on Types the Market is categorized into Below types that held the largest Cancer Biopsy market share In 2023.
Tissue Biopsies
Liquid Biopsies
Others
Japan (United States, Japan and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Cancer Biopsy Market Research Analysis
1. Introduction of the Japan Cancer Biopsy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Japan Cancer Biopsy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Japan Cancer Biopsy Market, By Type
6. Japan Cancer Biopsy Market, By Application
7. Japan Cancer Biopsy Market, By Geography
Japan
Europe
Asia Pacific
Rest of the World
8. Japan Cancer Biopsy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Japan Research and Consulting firm servicing over 5000+ Japan clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/